$SMME-Your Credit Card as an Intelligent Mobile De… – (SMME) (RLBD)

April 2015 Newsletter Ticker- SMME Price-.$.12 Exchange- OTC QB Shares/Out- 176.5 Mil Market Cap-21.18Mil Upcoming News Stay tuned for our new profiles and news releases! 1 jpeg Our social apps 2twitter.gif 3 facebook.gif 4 Recent Profiles Click on logo to learn more 5png 6 7jpeg 8 9png 10 Real Brands Inc.

Read more

$SMME-SmartMetric Welcomes the Dramatic Increase i… – (SMME) (RLBD)

April 2015 Newsletter Ticker- SMME Price-.$.09 Exchange- OTC QB Shares/Out- 176.5 Mil Market Cap-15.89Mil Upcoming News Stay tuned for our new profiles and news releases! 1 jpeg Our social apps 2twitter.gif 3 facebook.gif 4 Recent Profiles Click on logo to learn more 5png 6 7jpeg 8 9png 10 Real Brands Inc.

Read more

$SMME-SmartMetric Warns That the New EMV Chip Card… – (SMME) (RLBD)

April 2015 Newsletter Ticker- SMME Price-.$.0895 Exchange- OTC QB Shares/Out- 176.5 Mil Market Cap-15.8Mil Upcoming News Stay tuned for our new profiles and news releases! 1 jpeg Our social apps 2twitter.gif 3 facebook.gif 4 Recent Profiles Click on logo to learn more 5png 6 7jpeg 8 9png 10 Real Brands Inc

Read more

$PBIO-SeeThruEquity Issues Update on Pressure BioS… –

April 2015 Newsletter Ticker- PBIO Price-.$.35 Exchange- OTC QB Shares/Out- 19.07 Mil Market Cap-6.67Mil Upcoming News Stay tuned for our new profiles and news releases! 1 jpeg Our social apps 2twitter.gif 3 facebook.gif 4 Recent Profiles Click on logo to learn more 5 6jpeg 7 8jpeg 9png 10 Real Brands Inc.

Read more

TWSI ask .25, earnings breakout coming – (TWSI) (NATO) (PINC)

Wall Street Newscast Traders Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~TWSI has Real Potential for Run to $1.00+ (NEW YORK)—Tristar Wellnes Solutions, Inc. (OTC:TWSI), a leading developer and marketer of advanced medical products, reported revenues grew nearly 70% on growing sales of their hemostaic blood control product.Key Highlights – FDA approved – Sales up 70% to $4.4 million, projected higher for 2015 – Sales to military, NATO – Purchase order from NASDAQ listed Premier, Inc (PINC) – 24 million shares outstanding – Tightly held float – Projecting Profit in 2015 * Chart breaking out

Read more

TWSI has potential to run to $1.00 (chart breakou… – (TWSI) (NATO) (PINC)

Wall Street Newscast Traders Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~TWSI has Real Potential for Run to $1.00+ (NEW YORK)—Tristar Wellnes Solutions, Inc. (OTC:TWSI), a leading developer and marketer of advanced medical products, reported revenues grew nearly 70% on growing sales of their hemostaic blood control product.Key Highlights – FDA approved – Sales up 70% to $4.4 million, projected higher for 2015 – Sales to military, NATO – Purchase order from Premier, Inc (PINC) – 24 million shares outstanding – Tightly held float – Projecting Profit in 2015 * Chart breaking out!!

Read more

$LEAI issued $3 Price Target on .20/EPS – (LEAI) (WSNC)

Wall Street Newscast Traders Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LEAI Issued $3.00 Target Based on $0.20 EPS By: staff reporter, John Bodger Last Updated: February 23, 2015 12:41 pm EST (NEW YORK)—Ludlow Research, a small cap equity research firm based out of New york City, issued initial valuation opinion on Legacy Education Alliance, Inc. (OTC:LEAI), a leading provider of educational training seminars, with a valuation target of $2.00 to $3.00 per share.Financial Highlights – $75 million in revenue – $7.4 million net income (profit) – Around $0.20 cash per share – No debt or convertible notes In an initial note to subscriber, Ludlow Research pointed out potential for real upside valuation as LEAI currently trades at less then 5 times EPS.Nine Month Results For the nine months ending Sept. 30, 2014, the Company reported total revenues of around $75 million, with a total net income profit of $7.4 million.EPS of $0.20 Based on 20 million common shares issued and outstanding, a net income of $7.4 million gives LEAI roughly a $0.35 EPS.

Read more

TWSI (.15) chart breakout, FDA approved, only 24 m… – (TWSI) (NATO) (PINC)

Wall Street Newscast Traders Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~TWSI Chart Breakout on FDA Approval and Growing Revenues (NEW YORK)—Tristar Wellnes Solutions, Inc. (OTC:TWSI), a leading developer and marketer of advanced medical products, reported revenues grew nearly 70% on growing sales of their hemostaic blood control product.TWSI Key Highlights – FDA approval – Sales up 70%, projected higher for 2015 – Sales to military, NATO – Purchase order from Premier, Inc (PINC) – 24 million shares outstanding, low market cap Through their operating division, HemCon Medical Technologies, Inc., TWSI shows real market value as sales revenues grow from their FDA approved hemostatic medical products.Three Month Results For the three months ended September 30, 2014, the Company reported revenues rose roughly 50% to $1,908,000, as compared to $1,281,000 for the three months ended September 30, 2013.In addition to improving revenues, the Company reported a 66% decrease in operating loss for the quarter to approximately $501,000, compared to an operating loss of approximately $1,513,000 for the three months ended September 30, 2013.Nine Month Results For the nine months ended September 30, 2014, revenues rose roughly 70% to $4,435,000, as compared to $2,574,000 for same period in 2013, while our operating loss decreased 35% to $2,993,000, from $4,685,000 in the same nine month period in 2013.Major Purchase Agreement In November 2014, the Company announced it was awarded a group purchasing agreement with NASDAQ listed Premier, Inc.

Read more

GYST just 100k shares left at .0064, then breakout… – (GYST) (ALGA) (AFPW)

Wall Street Newscast Traders Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GYST Shows Very Few Shares from .0064 to .01 Breakout (NEW YORK)—The Graystone Company (OTC:GYST), a operational gold minning and exploration company, has all the pieces together for a strong and extended rally from below $0.01 per share.Less then 120,000 between $0.0064 to $0.01 breakout! Key Trader Points – Operational gold miner, not just developing exploration – Producing and processing gold – Gold stocks have been rallying strong in January – Only 42 million outstanding, float very tight – Market cap below $400,000 – Technical breakout on chart above $0.011 per share These alone are some good aspects for a trader play, and with potential for technical breakout on chart GYST also has an aspect that could really fuel a sustained rally from here.Reduced Risk of Dilution Into Rally In the old days investors who believed in a company would provide funding to see the company succeed long-term

Read more

GYST stage set for big run, read why here – (GYST) (ALGA) (AFPW)

Wall Street Newscast Traders Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GYST Has Potential for a Strong Sharp Rally from Here (NEW YORK)—The Graystone Company (OTC:GYST), a operational gold minning and exploration company, has all the pieces together for a strong and extended rally from below $0.01 per share.Key Trader Points – Operational gold miner, not just developing exploration – Producing and processing gold – Gold stocks have been rallying strong in January – Only 42 million outstanding, float very tight – Market cap below $400,000 – Technical breakout on chart above $0.011 per share These alone are some good aspects for a trader play, and with potential for technical breakout on chart GYST also has an aspect that could really fuel a sustained rally from here.Reduced Risk of Dilution Into Rally In the old days investors who believed in a company would provide funding to see the company succeed long-term. But in recent years traders have become all to aware of these toxic funders who have no long-term interest in the companies they finance, and once their investments have matured they tend to crush these small cap plays with relentless selling into the bids, or into any rallyies that can be achieved.GYST shares and notes are currently held in more friendly hands of investors who have a long-term interest in seeing the company succeed, and this greatly reduces risk of sudden selling into any rallies in the under lying stock.- Shares and Notes not held by toxic diluters – Reduced risk of selling into any rallies With only 42 million shares outstanding, and a market cap below $400,000, GYST offers real prospect for a decent trade from below $0.01 to potentially $0.05+ just based on chart alone

Read more